Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

38.47USD
24 May 2019
Change (% chg)

$0.68 (+1.80%)
Prev Close
$37.79
Open
$37.70
Day's High
$38.65
Day's Low
$37.68
Volume
2,036,170
Avg. Vol
1,846,076
52-wk High
$41.00
52-wk Low
$29.96

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $53,498.40
Shares Outstanding(Mil.): 1,390.65
Dividend: --
Yield (%): --

Financials

  BSX.N Industry Sector
P/E (TTM): 31.06 116.49 35.48
EPS (TTM): 1.24 -- --
ROI: 10.38 5.78 11.75
ROE: 21.39 8.15 16.52

Boston Scientific trims 2019 sales growth forecast on weak first quarter, shares fall

Boston Scientific Corp on Wednesday posted a rare first-quarter profit and revenue miss and lowered the top end of its 2019 sales growth forecast as the medical device maker faces regulatory scrutiny for some of its products.

Apr 24 2019

Boston Scientific sees $25 million hit to 2019 revenue from mesh withdrawal

Boston Scientific Corp on Wednesday said it expects a setback of about $25 million to its full-year revenue due to the U.S. Food and Drugs Administration's order to halt sales of its transvaginal surgical mesh products.

Apr 17 2019

Boston Scientific sees $25 mln hit to 2019 revenue from mesh withdrawal

April 17 Boston Scientific Corp on Wednesday said it expects a setback of about $25 million to its full-year revenue due to the U.S. Food and Drugs Administration's order to halt sales of its transvaginal surgical mesh products.

Apr 17 2019

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Jan 15 2019

UPDATE 2-Edward Lifesciences pays Boston Scientific $180 mln to end patent row

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Jan 15 2019

Edward Lifesciences settles patent disputes with Boston Scientific

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement related to all outstanding patent disputes between the companies, the medical device makers said in a joint statement on Tuesday.

Jan 15 2019

Edwards owes Boston Scientific $35 mln in heart valve patent case - jury

A federal jury in Delaware has ordered medical device maker Edwards Lifesciences Corp to pay $35 million after finding a heart valve replacement system it makes infringes a patent held by rival Boston Scientific Corp.

Dec 12 2018

Earnings vs. Estimates